BTC Health (ASX:BTC) 3-Year RORE % : -135.00% (As of Dec. 2025)


What is BTC Health 3-Year RORE %?

BTC Health ASX:BTC 3-Year RORE % is -135.00 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 1,293 Biotechnology companies, BTC Health ranks worse than 96.21% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. BTC Health's 3-Year RORE % for the quarter that ended in Dec. 2025 was -135.00%.

The industry rank for BTC Health's 3-Year RORE % or its related term are showing as below:

ASX:BTC's 3-Year RORE % is ranked worse than
96.21% of 1293 companies
in the Biotechnology industry
Industry Median: -11.55 vs ASX:BTC: -135.00

BTC Health  (ASX:BTC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


BTC Health 3-Year RORE % Related Terms


BTC Health 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for BTC Health's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BTC Health 3-Year RORE % Chart

BTC Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.50 20.00 85.00 -14.29 -228.57

BTC Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.35 -14.29 -78.95 -228.57 -135.00

ASX:BTC vs VRTX, REGN, ALNY: 3-Year RORE % Comparison

For the Biotechnology subindustry, BTC Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTC Health 3-Year RORE % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTC Health's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where BTC Health's 3-Year RORE % falls into.



BTC Health 3-Year RORE % Calculation

BTC Health's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.003--0.03 )/( -0.02-0 )
=0.027/-0.02
=-135.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -135.00 mean?
BTC Health (ASX:BTC) has a 3-Year RORE % of -135.00 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BTC Health and its competitors. According to the industry distribution chart, BTC Health ranks #1244 out of 1293 companies in the Biotechnology industry, placing it in the top 96.2%.
Is BTC Health's 3-Year RORE % too high?
BTC Health's current 3-Year RORE % is -135.00. Based on the distribution chart, BTC Health ranks #1244 out of 1293 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BTC Health's 3-Year RORE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BTC Health ranks #1244 out of 1293 companies for 3-Year RORE %. This places BTC Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Biotechnology company?
A good 3-Year RORE % depends on the Biotechnology industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BTC Health and its competitors. BTC Health's current 3-Year RORE % is -135.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BTC Health stock overvalued right now?
BTC Health (ASX:BTC) has a current 3-Year RORE % of -135.00. The current 3-Year RORE % is -135.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For BTC Health (ASX:BTC), the current 3-Year RORE % is -135.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BTC Health Business Description

Address 10 Oxley Road, Level 1, Hawthorn, Melbourne, VIC, AUS, 3122
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.